What are the ACOG guidelines for diagnosing and managing placenta previa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ACOG Guidelines for Placenta Previa: Diagnosis and Management

Placenta previa should be diagnosed using transvaginal ultrasound, which is the gold standard imaging modality, and women with confirmed placenta previa require planned cesarean delivery at 34 0/7 to 35 6/7 weeks of gestation at a facility equipped for massive transfusion protocols. 1

Diagnostic Approach

Initial Screening and Imaging

  • Perform transabdominal ultrasound first as a screening tool to visualize the placenta, inferior placental margin, and cervix from external to internal os 2
  • Follow with transvaginal ultrasound for definitive diagnosis when placenta previa is suspected, as this provides superior accuracy with sensitivity of 90.7% and specificity of 96.9% 1
  • Never perform digital pelvic examination until placenta previa has been excluded by ultrasound, as this can trigger catastrophic hemorrhage 2, 1
  • Add color Doppler evaluation to identify any vessels overlying the internal cervical os (vasa previa) and assess placental blood flow patterns 2

Classification and Follow-Up

  • Placenta previa is diagnosed when the placenta overlies the internal cervical os 1
  • Low-lying placenta is defined as placental edge within 2 cm of the internal os but not covering it 3
  • If placenta reaches or overlaps the internal os at 18-22 weeks, perform follow-up ultrasound at 28-32 weeks to reassess position, as many cases resolve with advancing gestation 2, 3
  • If placenta is ≥2 cm from the internal os at 18-20 weeks, no further follow-up is necessary 3

Risk Assessment for Placenta Accreta Spectrum

Critical Risk Stratification

  • All women with placenta previa AND prior cesarean deliveries must be evaluated for placenta accreta spectrum disorder, as this combination dramatically increases morbidity and mortality 2, 1
  • The risk increases 7-fold after one prior cesarean and up to 56-fold after three cesarean deliveries 2, 1
  • Additional risk factors include: advanced maternal age, high parity, in vitro fertilization, prior myomectomy or D&C, prior postpartum hemorrhage, Asherman syndrome, uterine anomalies, smoking, and hypertension 2

Imaging for Accreta Spectrum

  • Ultrasound with color Doppler has sensitivity of 77-97% and specificity of 96-98% for detecting placenta accreta 2
  • Consider MRI without IV contrast when ultrasound is equivocal, for posterior placentation, or when obesity limits ultrasound assessment 2
  • Do not routinely use gadolinium-based contrast agents, as there is insufficient evidence of benefit and potential fetal risk 2

Management Strategy

Antepartum Management

  • Hospitalize immediately for any active bleeding episode 1
  • Before 28 weeks with asymptomatic placenta previa, moderate-to-vigorous physical activity is acceptable 1
  • After 28 weeks, restrict moderate-to-vigorous activity but allow activities of daily living and walking 1
  • Optimize hemoglobin values during pregnancy by treating anemia with oral or intravenous iron 1
  • Women with one bleeding episode are at increased risk for subsequent hemorrhage and require closer surveillance 1

Delivery Planning and Timing

Optimal Gestational Age

  • ACOG recommends planned cesarean delivery at 34 0/7 to 35 6/7 weeks for uncomplicated placenta previa 1
  • Do not delay delivery beyond 36 0/7 weeks, as approximately 50% of women with placenta accreta spectrum beyond 36 weeks require emergent delivery for hemorrhage 1
  • Deliver earlier than 34 weeks for persistent bleeding, preeclampsia, labor, rupture of membranes, or fetal compromise 1
  • Administer antenatal corticosteroids when delivery is anticipated before 37 0/7 weeks 1

Facility and Team Requirements

  • Delivery must occur at a level III or IV maternal care facility with multidisciplinary expertise 1
  • Assemble a team including: maternal-fetal medicine subspecialists, pelvic surgeons, urologists, interventional radiologists, obstetric anesthesiologists, and neonatologists 1
  • Notify blood bank in advance due to frequent need for large-volume transfusion and ensure massive transfusion protocols are available 1

Intraoperative Management

Surgical Approach

  • Make the uterine incision away from the placenta when possible 1
  • After fetal delivery, leave the placenta in situ if there is evidence of abnormal placental attachment 1
  • Never attempt forced placental removal, as this causes profuse hemorrhage 1, 4
  • Consider dorsal lithotomy positioning to allow vaginal access and optimal surgical visualization 1

Management of Placenta Accreta Spectrum

  • For confirmed placenta accreta spectrum, the most accepted approach is cesarean hysterectomy with placenta left in place 1, 4
  • For suspected bladder involvement, place ureteric stents preoperatively and have urologic surgeons available 1
  • Have a contingency plan for emergent delivery, as patients are at increased risk of prepartum hemorrhage as gestational age increases 2

Hemorrhage Management

  • Transfuse packed red blood cells, fresh frozen plasma, and platelets in a 1:1:1 to 1:2:4 ratio for massive hemorrhage 1, 4
  • Maintain patient temperature >36°C, as clotting factors function poorly at lower temperatures 1
  • Re-dose prophylactic antibiotics if blood loss ≥1,500 mL 1
  • Obtain baseline labs at bleeding initiation: platelet count, PT, PTT, and fibrinogen 1

Postoperative Care

  • Provide intensive hemodynamic monitoring in the early postoperative period, often in an ICU setting 1
  • Maintain low threshold for reoperation if ongoing bleeding is suspected 1
  • Ensure adequate iron supplementation and follow-up of hemoglobin levels if significant blood loss occurred 1

Special Considerations for Vaginal Delivery

  • Vaginal delivery may be attempted when the placental edge is >2 cm from the internal cervical os at term 5, 6
  • Cesarean delivery is mandatory when the placenta overlaps the internal os 1, 5
  • When distance is <2 cm, vaginal delivery is possible but monitor closely for hemorrhage 6, 7

Common Pitfalls to Avoid

  • Failing to perform transvaginal ultrasound for accurate diagnosis, relying only on transabdominal imaging 3
  • Missing placenta accreta spectrum in women with anterior placenta previa and prior cesarean deliveries, which can lead to catastrophic hemorrhage 2, 3
  • Delaying delivery beyond 36 weeks in an attempt to achieve term gestation, which significantly increases emergency delivery risk 1
  • Attempting manual placental removal when accreta is encountered, which causes massive hemorrhage 1, 4

References

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Low-Lying Anterior Placenta: Definition, Diagnosis, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Immediate Management of Hemorrhaging Placenta Previa at 22 Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Placenta previa, placenta accreta, and vasa previa.

Obstetrics and gynecology, 2006

Research

Recent advances in the management of placenta previa.

Current opinion in obstetrics & gynecology, 2004

Research

[Management of placenta previa and accreta].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2014

Related Questions

What are the classifications and risk factors of placenta previa?
What are the different types of placental previa and their management strategies?
What are the delivery recommendations for patients with placenta previa?
What is the recommended delivery option for a patient with persistent placenta previa at 36-37 weeks gestation, with no episodes of antepartum bleeding, who conceived via in vitro fertilization (IVF)?
What is the recommended delivery option for a patient with persistent placenta previa, no antepartum bleeding, and a confirmed diagnosis via repeat ultrasound at an estimated gestational age, to maximize maternal and neonatal outcomes?
In a patient with moderately increased albuminuria (urine albumin‑to‑creatinine ratio ~200 mg/g) on submaximal lisinopril and blood pressure above 130/80 mmHg, who exhibits intermittent tachycardia (heart rate 115, 108, 86, 83, 100, 95, 94, 105 bpm), should a beta‑blocker be added as the next antihypertensive medication?
How conclusive is a negative rapid plasma reagin test at 41 days post‑exposure combined with a negative treponemal test at 51 days for ruling out active syphilis?
In tumor‑related vasogenic cerebral edema, can intravenous steroids be used, and if so, which steroid is preferred, what dosing regimen should be employed, and how long should treatment be continued?
What are the recommended guidelines for prescribing long‑term opioid analgesics to adult patients with chronic moderate‑to‑severe pain?
Is trazodone appropriate for sleep in an older postoperative cardiac surgery patient on multiple cardiovascular drugs with reduced renal/hepatic clearance and QT‑prolongation risk?
What is the current recommendation for daily low‑dose aspirin (81 mg) in adults, including indications for secondary prevention and criteria for primary prevention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.